Marc A. Cohen is Co-founder, Executive Chairman, and CEO of C4 Therapeutics. Marc is also the Executive Chairman of Frequency Therapeutics (NASDAQ: FREQ) and Co-Founder of Cobro Ventures, Inc. Previously, he was Chairman and Co-founder of Acetylon Pharmaceuticals (sold to Celgene) and OPNET Technologies, Inc. (sold to Riverbed Technology). Marc received a Bachelor of Science in engineering from Harvard University and a Master of Science in electrical engineering from Stanford University. He is a Trustee of the Dana-Farber Cancer Institute where he is focusing on accelerating translational research and increasing the flow of new therapies to patients.